International Journal of Medical Toxicology & Legal Medicine
  • Year: 2021
  • Volume: 24
  • Issue: 3and4

Hemochromatosis due to parenteral iron therapy

1Pathology Department, College of Medicine, Taif University, P. O. Box 11099, Taif21944, Saudi Arabia, amakki@tu.edu.sa

2Professor of Clinical Toxicology, Faculty of Medicine, Taif University (KSA) and Minia University (Egypt). mfabbas@tu.edu.sa

*Corresponding Author Amin A. Alamin Pathology DepartmentCollege of Medicine, Taif University, P.O. Box 11099, Taif21944, Saudi Arabia Email: amakki@tu.edu.sa

Online published on 21 March, 2022.

Abstract

Iron overload is caused by mutations in the HFE gene that stimulate absorption, or when the amount ingested or injected exceeds the body's ability to eliminate it. Excessive iron deposition in the parenchymal tissue leads to injury and ultimately organ dysfunction. Diabetes mellitus and liver cirrhosis due to damage to the pancreas and liver are examples of diseases caused by iron overload.

We report a 6-year-old boy who developed iron overload due to iatrogenic intravenous iron injections. Iron toxicity can be an incidental finding, such as unexplained elevated serum ferritin levels or unexplained liver disease, which may trigger an iron overload investigation.

This case illustrates the importance of prescribing intravenous iron by expert physicians to avoid toxicity.

Keywords

Acquired Hemochromatosis, Iron overload, Liver iron concentration, Parenteral iron therapy